Menu
Log in

Patent Information Users Group, Inc.

The International Society for Patent Information Professionals

Log in

Patent Information Users Group, Inc.  The International Society for Patent Information Professionals

  • Home
  • Patent Information and related events May 11-14, 2021 (May 11: CPA Global: Patent monitoring @11:00am ET; May 12: EMBL-EBI: ChEMBL (drug-like compounds & biological targets) @ 10:30 AM ET; May 14: USPTO: Patent application drafting @ 1 pm ET (register by 1 pm ET May 13)
  • Home
  • Patent Information and related events May 11-14, 2021 (May 11: CPA Global: Patent monitoring @11:00am ET; May 12: EMBL-EBI: ChEMBL (drug-like compounds & biological targets) @ 10:30 AM ET; May 14: USPTO: Patent application drafting @ 1 pm ET (register by 1 pm ET May 13)


Patent Information and related events May 11-14, 2021 (May 11: CPA Global: Patent monitoring @11:00am ET; May 12: EMBL-EBI: ChEMBL (drug-like compounds & biological targets) @ 10:30 AM ET; May 14: USPTO: Patent application drafting @ 1 pm ET (register by 1 pm ET May 13)

  • 10 May 2021 11:49 PM
    Message # 10464493

    The following patent information and related events are offered May 11-14, 2021:

     

    Tuesday, May 11, 2021
    11:00am – 12:00pm ET | 6:00 – 7:00 pm CET
    CPA Global  
    Realizing the business value of patent intelligence through patent monitoring          Registration
    In this session we will explore how creating a comprehensive patent monitoring program  [and] acontextualizes this within your IP landscape…
    [
    How a competitor’s strategy is evolving; How emerging technologies are enabling new business models; How new inventions from unexpected sources are creating freedom to operate (FTO) and litigation risk.]

    See also:
    Philllips, Shayne (Six Points Consulting). Realizing the business value of patent intelligence through patent monitoring. CPA Global. blog, April 26, 2021
    (“So how can these traditional approaches to taxonomy (R&D unit, Inventive Process Cost; IP Prep and Prosecution Cost; Family Maintenance Cost, Business Profit center, Product Hierarchy – see a Table within the blog) be extended to also support your broader business strategy? One solution is to take a value stream approach. A technology-based taxonomy that maps each stage where additional value is added on the journey toward the end consumer – i.e. your R&D, legal and business stakeholders….Join us on May 11th where we will present a six-step approach to creating a comprehensive patent monitoring program…)


    Wednesday, May 12, 2021

    10:30 – 11:30 am ET | 4:30 – 5:30 pm CET
    EMBL-EBI Training:
    A guide to exploring drug-like compounds and their biological targets using ChEMBL
    Registration
    This webinar will provide an overview of the ChEMBL web interface, data types within ChEMBL and how ChEMBL can be used to answer questions relevant to medicinal chemistry and drug discovery
    See also: ChEMBL: Bioactive data for drug discovery  (ChEMBL is a manually curated database of bioactive molecules with drug-like properties. It brings together chemical, bioactivity and genomic data to aid the translation of genomic information into effective new drugs)
    As of May 10, 2021: 14,347 Targets; 2,086,898 Distinct compounds; 17,276,334 Activities; 80,480 Publications; 170 Deposited Datasets
    Patent Bioactivity Data in ChEMBL. A  current ChEMBL 28 release (Jan. 15, 2021) Patent Bioactivity Data includes 10,796 Compounds, 48,767 Records and 138,355 activities.  As noted in [1]  “[ChEMBL] data extraction effort is focused on patents containing compounds and bioactivity data for targets that are not currently well represented in ChEMBL (and in particular, those of interest to the NIH Illuminating the Druggable Genome project…” Also ChEMBL has patent bioactivity data extracted from BindingDB dataset which include data from curation of 2013-mid 2020 US patent  data. As of May 5, 2012,
    ChEMBL has data from 1899 patents from BinndingDB dataset and from 498 patents from ChEMBL Patent Bioactivity Data.
      [1] Mendez, D., Gaulton, A., Bento et al.  (January 2019). ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Research 47 (D1), D930–D940. https://doi.org/10.1093/nar/gky1075

     

     


    Friday, May 14, 2021
    1-3 pm ET | 7-8 pm CET
    USPTO.
    The Path to a Patent, Part IV: Learn how to draft a patent application   Registration by 1 PM ET 5/13
    Formalities and requirements of drafting a patent application.
    See also:
    Content of  Jeff Palenik (USPTO Primary Patent Examiner)  presentation: Utility Patent Application Disclosure Drafting, (Oct.30, 2020, 41 p.): …Specification; …Specification Sections [discussed in detail later]; Title of the Invention; Lesser used sections (Cross reference to related applications, Incorporation by reference…); Background of the Invention; Brief Summary of the Invention; Brief Description of the Drawings; Drawings;
    Drawing Requirements; Abstract; Detailed Description of the Invention; Specification DOs; Specification Cautions; Claim(s); Form of Claim(s); U.S. Patent Law Requirements [for claims]; Claims [too specific vs. invention vs.too general]; Before Drafting Claims; Thinking Strategically; Claim Drafting; Claim Example; Claim Drafting DOs; Claim Drafting Cautions.
    Quinn, Gene.. How to Write a Patent Application. IPWatchdog.com Blog, August 11, 2018.
    (and references for other related author's blog posts therein)

     

     

    Update 5/11/2021 1:00 AM  Information on Understanding The Patent Process webinar 5/11/2021 & additional info to patent application drafting 5/14/2021 has been added.

    Update 5/11/2021 12:06 PM Info on Patent Biactivity data in ChEMBL has been added.

    Update 5/12/2021 1:00 AM  Information on Understanding The Patent Process webinar 5/11/2021 has been deleted [too basic for this forum].

    Last modified: 12 May 2021 10:19 AM | Anonymous member

In this Section:

PIUG - Patent Information User Group, Inc.

Mailing Address:  
40 E. Main St., #1438
Newark, DE  19711

Phone: +1 (302) 660-3275   
Fax: +1 (302) 660-3276
Email: PIUGinfo@piug.org

Webmaster: webmaster@piug.org

Notice on use of PIUG name and logo:  

No one may use the PIUG name or logo for any promotional or commercial purpose or any other purpose without the prior written consent of the PIUG Board of Directors.  

Antitrust Policy | Bylaws  |  Copyright and Disclaimer

© 2024 The Patent Information Users Group, Inc.

Powered by Wild Apricot Membership Software